Amazon announced its intent to purchase online pharmacy PillPack for about $1 billion in June. The pharmacy deal, coupled with its dominant Prime service that offers free two-day shipping, makes Amazon’s push into the pharmacy space logical, and the survey findings pose a huge opportunity for the online retailer, according to Deutsche Bank analysts.
“Amazon has a history of starting small, testing the market and fine-tuning the service before launching a full-fledged commercial operation,” analysts wrote, according to CNBC. “As such, we believe it is a question of when and where — and not if — Amazon enters the healthcare space more forcefully.”
Once the Amazon-PillPack transaction is closed, analysts predict that Amazon will make headway in the mail order pharmacy market and may even use its 450 Whole Foods stores as prescription pick-up locations.
According to Lloyd Walmsley, an analyst at Deutsche, if Amazon can gain a 30 percent share of the mail order pharmacy market, which is valued at $22 billion, as well as about $55 billion of front office sales and obtain 4 percent of U.S. online healthcare advertising, it could add $3 billion in gross profit from its entrance into the pharmacy arena.
Read the full article here.
More articles on pharmacy:
Hospitals mark up drugs by 479%: 6 report findings
6 latest drug, medical device recalls
400% price hike for generic drug a ‘moral requirement,’ Missouri pharma CEO says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.